Global Opioids Agonist Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
LPI (LP Information)' newest research report, the “Opioids Agonist Drugs Industry Forecast” looks at past sales and reviews total world Opioids Agonist Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioids Agonist Drugs sales for 2023 through 2029. With Opioids Agonist Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioids Agonist Drugs industry.
This Insight Report provides a comprehensive analysis of the global Opioids Agonist Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioids Agonist Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Opioids Agonist Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioids Agonist Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioids Agonist Drugs.
The global Opioids Agonist Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Agonist Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Opioids Agonist Drugs market?
What factors are driving Opioids Agonist Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Agonist Drugs market opportunities vary by end market size?
How does Opioids Agonist Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
LPI (LP Information)' newest research report, the “Opioids Agonist Drugs Industry Forecast” looks at past sales and reviews total world Opioids Agonist Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioids Agonist Drugs sales for 2023 through 2029. With Opioids Agonist Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioids Agonist Drugs industry.
This Insight Report provides a comprehensive analysis of the global Opioids Agonist Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioids Agonist Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Opioids Agonist Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioids Agonist Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioids Agonist Drugs.
The global Opioids Agonist Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Agonist Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Pain Management
- Cough Treatment
- Diarrhea Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Purdue Pharma
- Titan pharmaceuticals
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.
- Allergan, Plc
- Pfizer Inc
What is the 10-year outlook for the global Opioids Agonist Drugs market?
What factors are driving Opioids Agonist Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Agonist Drugs market opportunities vary by end market size?
How does Opioids Agonist Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Agonist Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Opioids Agonist Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Opioids Agonist Drugs by Country/Region, 2018, 2022 & 2029
2.2 Opioids Agonist Drugs Segment by Type
2.2.1 Codeine
2.2.2 Fentanyl
2.2.3 Meperidine
2.2.4 Methadone
2.2.5 Morphine
2.2.6 Hydrocodone
2.3 Opioids Agonist Drugs Sales by Type
2.3.1 Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Opioids Agonist Drugs Sale Price by Type (2018-2023)
2.4 Opioids Agonist Drugs Segment by Application
2.4.1 Pain Management
2.4.2 Cough Treatment
2.4.3 Diarrhea Treatment
2.5 Opioids Agonist Drugs Sales by Application
2.5.1 Global Opioids Agonist Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Opioids Agonist Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Opioids Agonist Drugs Sale Price by Application (2018-2023)
3 GLOBAL OPIOIDS AGONIST DRUGS BY COMPANY
3.1 Global Opioids Agonist Drugs Breakdown Data by Company
3.1.1 Global Opioids Agonist Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Opioids Agonist Drugs Sales Market Share by Company (2018-2023)
3.2 Global Opioids Agonist Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Opioids Agonist Drugs Revenue by Company (2018-2023)
3.2.2 Global Opioids Agonist Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Opioids Agonist Drugs Sale Price by Company
3.4 Key Manufacturers Opioids Agonist Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Agonist Drugs Product Location Distribution
3.4.2 Players Opioids Agonist Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS AGONIST DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Opioids Agonist Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Opioids Agonist Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Opioids Agonist Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Opioids Agonist Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Opioids Agonist Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Opioids Agonist Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Opioids Agonist Drugs Sales Growth
4.4 APAC Opioids Agonist Drugs Sales Growth
4.5 Europe Opioids Agonist Drugs Sales Growth
4.6 Middle East & Africa Opioids Agonist Drugs Sales Growth
5 AMERICAS
5.1 Americas Opioids Agonist Drugs Sales by Country
5.1.1 Americas Opioids Agonist Drugs Sales by Country (2018-2023)
5.1.2 Americas Opioids Agonist Drugs Revenue by Country (2018-2023)
5.2 Americas Opioids Agonist Drugs Sales by Type
5.3 Americas Opioids Agonist Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Agonist Drugs Sales by Region
6.1.1 APAC Opioids Agonist Drugs Sales by Region (2018-2023)
6.1.2 APAC Opioids Agonist Drugs Revenue by Region (2018-2023)
6.2 APAC Opioids Agonist Drugs Sales by Type
6.3 APAC Opioids Agonist Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Agonist Drugs by Country
7.1.1 Europe Opioids Agonist Drugs Sales by Country (2018-2023)
7.1.2 Europe Opioids Agonist Drugs Revenue by Country (2018-2023)
7.2 Europe Opioids Agonist Drugs Sales by Type
7.3 Europe Opioids Agonist Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Agonist Drugs by Country
8.1.1 Middle East & Africa Opioids Agonist Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Opioids Agonist Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Opioids Agonist Drugs Sales by Type
8.3 Middle East & Africa Opioids Agonist Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Agonist Drugs
10.3 Manufacturing Process Analysis of Opioids Agonist Drugs
10.4 Industry Chain Structure of Opioids Agonist Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Agonist Drugs Distributors
11.3 Opioids Agonist Drugs Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS AGONIST DRUGS BY GEOGRAPHIC REGION
12.1 Global Opioids Agonist Drugs Market Size Forecast by Region
12.1.1 Global Opioids Agonist Drugs Forecast by Region (2024-2029)
12.1.2 Global Opioids Agonist Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Agonist Drugs Forecast by Type
12.7 Global Opioids Agonist Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Purdue Pharma
13.1.1 Purdue Pharma Company Information
13.1.2 Purdue Pharma Opioids Agonist Drugs Product Portfolios and Specifications
13.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Purdue Pharma Main Business Overview
13.1.5 Purdue Pharma Latest Developments
13.2 Titan pharmaceuticals
13.2.1 Titan pharmaceuticals Company Information
13.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Titan pharmaceuticals Main Business Overview
13.2.5 Titan pharmaceuticals Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Janssen Pharmaceuticals, Inc
13.4.1 Janssen Pharmaceuticals, Inc Company Information
13.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Portfolios and Specifications
13.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Janssen Pharmaceuticals, Inc Main Business Overview
13.4.5 Janssen Pharmaceuticals, Inc Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Opioids Agonist Drugs Product Portfolios and Specifications
13.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Sun Pharmaceuticals
13.6.1 Sun Pharmaceuticals Company Information
13.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sun Pharmaceuticals Main Business Overview
13.6.5 Sun Pharmaceuticals Latest Developments
13.7 Mallinckrodt Pharmaceuticals
13.7.1 Mallinckrodt Pharmaceuticals Company Information
13.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.7.5 Mallinckrodt Pharmaceuticals Latest Developments
13.8 Egalet Corporation
13.8.1 Egalet Corporation Company Information
13.8.2 Egalet Corporation Opioids Agonist Drugs Product Portfolios and Specifications
13.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Egalet Corporation Main Business Overview
13.8.5 Egalet Corporation Latest Developments
13.9 Endo Pharmaceuticals Inc.
13.9.1 Endo Pharmaceuticals Inc. Company Information
13.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Portfolios and Specifications
13.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Endo Pharmaceuticals Inc. Main Business Overview
13.9.5 Endo Pharmaceuticals Inc. Latest Developments
13.10 Allergan, Plc
13.10.1 Allergan, Plc Company Information
13.10.2 Allergan, Plc Opioids Agonist Drugs Product Portfolios and Specifications
13.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Allergan, Plc Main Business Overview
13.10.5 Allergan, Plc Latest Developments
13.11 Pfizer Inc
13.11.1 Pfizer Inc Company Information
13.11.2 Pfizer Inc Opioids Agonist Drugs Product Portfolios and Specifications
13.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Pfizer Inc Main Business Overview
13.11.5 Pfizer Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Agonist Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Opioids Agonist Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Opioids Agonist Drugs by Country/Region, 2018, 2022 & 2029
2.2 Opioids Agonist Drugs Segment by Type
2.2.1 Codeine
2.2.2 Fentanyl
2.2.3 Meperidine
2.2.4 Methadone
2.2.5 Morphine
2.2.6 Hydrocodone
2.3 Opioids Agonist Drugs Sales by Type
2.3.1 Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Opioids Agonist Drugs Sale Price by Type (2018-2023)
2.4 Opioids Agonist Drugs Segment by Application
2.4.1 Pain Management
2.4.2 Cough Treatment
2.4.3 Diarrhea Treatment
2.5 Opioids Agonist Drugs Sales by Application
2.5.1 Global Opioids Agonist Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Opioids Agonist Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Opioids Agonist Drugs Sale Price by Application (2018-2023)
3 GLOBAL OPIOIDS AGONIST DRUGS BY COMPANY
3.1 Global Opioids Agonist Drugs Breakdown Data by Company
3.1.1 Global Opioids Agonist Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Opioids Agonist Drugs Sales Market Share by Company (2018-2023)
3.2 Global Opioids Agonist Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Opioids Agonist Drugs Revenue by Company (2018-2023)
3.2.2 Global Opioids Agonist Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Opioids Agonist Drugs Sale Price by Company
3.4 Key Manufacturers Opioids Agonist Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Agonist Drugs Product Location Distribution
3.4.2 Players Opioids Agonist Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS AGONIST DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Opioids Agonist Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Opioids Agonist Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Opioids Agonist Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Opioids Agonist Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Opioids Agonist Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Opioids Agonist Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Opioids Agonist Drugs Sales Growth
4.4 APAC Opioids Agonist Drugs Sales Growth
4.5 Europe Opioids Agonist Drugs Sales Growth
4.6 Middle East & Africa Opioids Agonist Drugs Sales Growth
5 AMERICAS
5.1 Americas Opioids Agonist Drugs Sales by Country
5.1.1 Americas Opioids Agonist Drugs Sales by Country (2018-2023)
5.1.2 Americas Opioids Agonist Drugs Revenue by Country (2018-2023)
5.2 Americas Opioids Agonist Drugs Sales by Type
5.3 Americas Opioids Agonist Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Agonist Drugs Sales by Region
6.1.1 APAC Opioids Agonist Drugs Sales by Region (2018-2023)
6.1.2 APAC Opioids Agonist Drugs Revenue by Region (2018-2023)
6.2 APAC Opioids Agonist Drugs Sales by Type
6.3 APAC Opioids Agonist Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Agonist Drugs by Country
7.1.1 Europe Opioids Agonist Drugs Sales by Country (2018-2023)
7.1.2 Europe Opioids Agonist Drugs Revenue by Country (2018-2023)
7.2 Europe Opioids Agonist Drugs Sales by Type
7.3 Europe Opioids Agonist Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Agonist Drugs by Country
8.1.1 Middle East & Africa Opioids Agonist Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Opioids Agonist Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Opioids Agonist Drugs Sales by Type
8.3 Middle East & Africa Opioids Agonist Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Agonist Drugs
10.3 Manufacturing Process Analysis of Opioids Agonist Drugs
10.4 Industry Chain Structure of Opioids Agonist Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Agonist Drugs Distributors
11.3 Opioids Agonist Drugs Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS AGONIST DRUGS BY GEOGRAPHIC REGION
12.1 Global Opioids Agonist Drugs Market Size Forecast by Region
12.1.1 Global Opioids Agonist Drugs Forecast by Region (2024-2029)
12.1.2 Global Opioids Agonist Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Agonist Drugs Forecast by Type
12.7 Global Opioids Agonist Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Purdue Pharma
13.1.1 Purdue Pharma Company Information
13.1.2 Purdue Pharma Opioids Agonist Drugs Product Portfolios and Specifications
13.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Purdue Pharma Main Business Overview
13.1.5 Purdue Pharma Latest Developments
13.2 Titan pharmaceuticals
13.2.1 Titan pharmaceuticals Company Information
13.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Titan pharmaceuticals Main Business Overview
13.2.5 Titan pharmaceuticals Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Janssen Pharmaceuticals, Inc
13.4.1 Janssen Pharmaceuticals, Inc Company Information
13.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Portfolios and Specifications
13.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Janssen Pharmaceuticals, Inc Main Business Overview
13.4.5 Janssen Pharmaceuticals, Inc Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Opioids Agonist Drugs Product Portfolios and Specifications
13.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Sun Pharmaceuticals
13.6.1 Sun Pharmaceuticals Company Information
13.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sun Pharmaceuticals Main Business Overview
13.6.5 Sun Pharmaceuticals Latest Developments
13.7 Mallinckrodt Pharmaceuticals
13.7.1 Mallinckrodt Pharmaceuticals Company Information
13.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
13.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.7.5 Mallinckrodt Pharmaceuticals Latest Developments
13.8 Egalet Corporation
13.8.1 Egalet Corporation Company Information
13.8.2 Egalet Corporation Opioids Agonist Drugs Product Portfolios and Specifications
13.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Egalet Corporation Main Business Overview
13.8.5 Egalet Corporation Latest Developments
13.9 Endo Pharmaceuticals Inc.
13.9.1 Endo Pharmaceuticals Inc. Company Information
13.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Portfolios and Specifications
13.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Endo Pharmaceuticals Inc. Main Business Overview
13.9.5 Endo Pharmaceuticals Inc. Latest Developments
13.10 Allergan, Plc
13.10.1 Allergan, Plc Company Information
13.10.2 Allergan, Plc Opioids Agonist Drugs Product Portfolios and Specifications
13.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Allergan, Plc Main Business Overview
13.10.5 Allergan, Plc Latest Developments
13.11 Pfizer Inc
13.11.1 Pfizer Inc Company Information
13.11.2 Pfizer Inc Opioids Agonist Drugs Product Portfolios and Specifications
13.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Pfizer Inc Main Business Overview
13.11.5 Pfizer Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioids Agonist Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Opioids Agonist Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Codeine
Table 4. Major Players of Fentanyl
Table 5. Major Players of Meperidine
Table 6. Major Players of Methadone
Table 7. Major Players of Morphine
Table 8. Major Players of Hydrocodone
Table 9. Global Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Opioids Agonist Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Opioids Agonist Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Opioids Agonist Drugs Revenue by Application (2018-2023)
Table 17. Global Opioids Agonist Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Opioids Agonist Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global Opioids Agonist Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Opioids Agonist Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Opioids Agonist Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Opioids Agonist Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Opioids Agonist Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers Opioids Agonist Drugs Producing Area Distribution and Sales Area
Table 25. Players Opioids Agonist Drugs Products Offered
Table 26. Opioids Agonist Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Opioids Agonist Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Opioids Agonist Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Opioids Agonist Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Opioids Agonist Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Opioids Agonist Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Opioids Agonist Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Opioids Agonist Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Opioids Agonist Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Opioids Agonist Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Opioids Agonist Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Opioids Agonist Drugs
Table 62. Key Market Challenges & Risks of Opioids Agonist Drugs
Table 63. Key Industry Trends of Opioids Agonist Drugs
Table 64. Opioids Agonist Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Opioids Agonist Drugs Distributors List
Table 67. Opioids Agonist Drugs Customer List
Table 68. Global Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Opioids Agonist Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Opioids Agonist Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Opioids Agonist Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Opioids Agonist Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Opioids Agonist Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Opioids Agonist Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Purdue Pharma Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Purdue Pharma Opioids Agonist Drugs Product Portfolios and Specifications
Table 84. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Purdue Pharma Main Business
Table 86. Purdue Pharma Latest Developments
Table 87. Titan pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Titan pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 89. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Titan pharmaceuticals Main Business
Table 91. Titan pharmaceuticals Latest Developments
Table 92. Boehringer Ingelheim Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Opioids Agonist Drugs Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Boehringer Ingelheim Main Business
Table 96. Boehringer Ingelheim Latest Developments
Table 97. Janssen Pharmaceuticals, Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Portfolios and Specifications
Table 99. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Janssen Pharmaceuticals, Inc Main Business
Table 101. Janssen Pharmaceuticals, Inc Latest Developments
Table 102. Sanofi Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Opioids Agonist Drugs Product Portfolios and Specifications
Table 104. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Sun Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 109. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Sun Pharmaceuticals Main Business
Table 111. Sun Pharmaceuticals Latest Developments
Table 112. Mallinckrodt Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 114. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Mallinckrodt Pharmaceuticals Main Business
Table 116. Mallinckrodt Pharmaceuticals Latest Developments
Table 117. Egalet Corporation Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Egalet Corporation Opioids Agonist Drugs Product Portfolios and Specifications
Table 119. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Egalet Corporation Main Business
Table 121. Egalet Corporation Latest Developments
Table 122. Endo Pharmaceuticals Inc. Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Portfolios and Specifications
Table 124. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Endo Pharmaceuticals Inc. Main Business
Table 126. Endo Pharmaceuticals Inc. Latest Developments
Table 127. Allergan, Plc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Allergan, Plc Opioids Agonist Drugs Product Portfolios and Specifications
Table 129. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Allergan, Plc Main Business
Table 131. Allergan, Plc Latest Developments
Table 132. Pfizer Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pfizer Inc Opioids Agonist Drugs Product Portfolios and Specifications
Table 134. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Pfizer Inc Main Business
Table 136. Pfizer Inc Latest Developments
Table 1. Opioids Agonist Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Opioids Agonist Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Codeine
Table 4. Major Players of Fentanyl
Table 5. Major Players of Meperidine
Table 6. Major Players of Methadone
Table 7. Major Players of Morphine
Table 8. Major Players of Hydrocodone
Table 9. Global Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Opioids Agonist Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Opioids Agonist Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Opioids Agonist Drugs Revenue by Application (2018-2023)
Table 17. Global Opioids Agonist Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Opioids Agonist Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global Opioids Agonist Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Opioids Agonist Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Opioids Agonist Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Opioids Agonist Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Opioids Agonist Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers Opioids Agonist Drugs Producing Area Distribution and Sales Area
Table 25. Players Opioids Agonist Drugs Products Offered
Table 26. Opioids Agonist Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Opioids Agonist Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Opioids Agonist Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Opioids Agonist Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Opioids Agonist Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Opioids Agonist Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Opioids Agonist Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Opioids Agonist Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Opioids Agonist Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Opioids Agonist Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Opioids Agonist Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Opioids Agonist Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Opioids Agonist Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Opioids Agonist Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Opioids Agonist Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Opioids Agonist Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Opioids Agonist Drugs
Table 62. Key Market Challenges & Risks of Opioids Agonist Drugs
Table 63. Key Industry Trends of Opioids Agonist Drugs
Table 64. Opioids Agonist Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Opioids Agonist Drugs Distributors List
Table 67. Opioids Agonist Drugs Customer List
Table 68. Global Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Opioids Agonist Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Opioids Agonist Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Opioids Agonist Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Opioids Agonist Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Opioids Agonist Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Opioids Agonist Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Opioids Agonist Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Opioids Agonist Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Opioids Agonist Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Purdue Pharma Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Purdue Pharma Opioids Agonist Drugs Product Portfolios and Specifications
Table 84. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Purdue Pharma Main Business
Table 86. Purdue Pharma Latest Developments
Table 87. Titan pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Titan pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 89. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Titan pharmaceuticals Main Business
Table 91. Titan pharmaceuticals Latest Developments
Table 92. Boehringer Ingelheim Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Opioids Agonist Drugs Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Boehringer Ingelheim Main Business
Table 96. Boehringer Ingelheim Latest Developments
Table 97. Janssen Pharmaceuticals, Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Portfolios and Specifications
Table 99. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Janssen Pharmaceuticals, Inc Main Business
Table 101. Janssen Pharmaceuticals, Inc Latest Developments
Table 102. Sanofi Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Opioids Agonist Drugs Product Portfolios and Specifications
Table 104. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Sun Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 109. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Sun Pharmaceuticals Main Business
Table 111. Sun Pharmaceuticals Latest Developments
Table 112. Mallinckrodt Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Portfolios and Specifications
Table 114. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Mallinckrodt Pharmaceuticals Main Business
Table 116. Mallinckrodt Pharmaceuticals Latest Developments
Table 117. Egalet Corporation Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Egalet Corporation Opioids Agonist Drugs Product Portfolios and Specifications
Table 119. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Egalet Corporation Main Business
Table 121. Egalet Corporation Latest Developments
Table 122. Endo Pharmaceuticals Inc. Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Portfolios and Specifications
Table 124. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Endo Pharmaceuticals Inc. Main Business
Table 126. Endo Pharmaceuticals Inc. Latest Developments
Table 127. Allergan, Plc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Allergan, Plc Opioids Agonist Drugs Product Portfolios and Specifications
Table 129. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Allergan, Plc Main Business
Table 131. Allergan, Plc Latest Developments
Table 132. Pfizer Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pfizer Inc Opioids Agonist Drugs Product Portfolios and Specifications
Table 134. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Pfizer Inc Main Business
Table 136. Pfizer Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioids Agonist Drugs
Figure 2. Opioids Agonist Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Agonist Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Opioids Agonist Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Opioids Agonist Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Codeine
Figure 10. Product Picture of Fentanyl
Figure 11. Product Picture of Meperidine
Figure 12. Product Picture of Methadone
Figure 13. Product Picture of Morphine
Figure 14. Product Picture of Hydrocodone
Figure 15. Global Opioids Agonist Drugs Sales Market Share by Type in 2022
Figure 16. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Opioids Agonist Drugs Consumed in Pain Management
Figure 18. Global Opioids Agonist Drugs Market: Pain Management (2018-2023) & (K Units)
Figure 19. Opioids Agonist Drugs Consumed in Cough Treatment
Figure 20. Global Opioids Agonist Drugs Market: Cough Treatment (2018-2023) & (K Units)
Figure 21. Opioids Agonist Drugs Consumed in Diarrhea Treatment
Figure 22. Global Opioids Agonist Drugs Market: Diarrhea Treatment (2018-2023) & (K Units)
Figure 23. Global Opioids Agonist Drugs Sales Market Share by Application (2022)
Figure 24. Global Opioids Agonist Drugs Revenue Market Share by Application in 2022
Figure 25. Opioids Agonist Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Opioids Agonist Drugs Sales Market Share by Company in 2022
Figure 27. Opioids Agonist Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Opioids Agonist Drugs Revenue Market Share by Company in 2022
Figure 29. Global Opioids Agonist Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 40. Americas Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 48. APAC Opioids Agonist Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 59. Europe Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs in 2022
Figure 77. Manufacturing Process Analysis of Opioids Agonist Drugs
Figure 78. Industry Chain Structure of Opioids Agonist Drugs
Figure 79. Channels of Distribution
Figure 80. Global Opioids Agonist Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Opioids Agonist Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Opioids Agonist Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Opioids Agonist Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Opioids Agonist Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Opioids Agonist Drugs
Figure 2. Opioids Agonist Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Agonist Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Opioids Agonist Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Opioids Agonist Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Codeine
Figure 10. Product Picture of Fentanyl
Figure 11. Product Picture of Meperidine
Figure 12. Product Picture of Methadone
Figure 13. Product Picture of Morphine
Figure 14. Product Picture of Hydrocodone
Figure 15. Global Opioids Agonist Drugs Sales Market Share by Type in 2022
Figure 16. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Opioids Agonist Drugs Consumed in Pain Management
Figure 18. Global Opioids Agonist Drugs Market: Pain Management (2018-2023) & (K Units)
Figure 19. Opioids Agonist Drugs Consumed in Cough Treatment
Figure 20. Global Opioids Agonist Drugs Market: Cough Treatment (2018-2023) & (K Units)
Figure 21. Opioids Agonist Drugs Consumed in Diarrhea Treatment
Figure 22. Global Opioids Agonist Drugs Market: Diarrhea Treatment (2018-2023) & (K Units)
Figure 23. Global Opioids Agonist Drugs Sales Market Share by Application (2022)
Figure 24. Global Opioids Agonist Drugs Revenue Market Share by Application in 2022
Figure 25. Opioids Agonist Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Opioids Agonist Drugs Sales Market Share by Company in 2022
Figure 27. Opioids Agonist Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Opioids Agonist Drugs Revenue Market Share by Company in 2022
Figure 29. Global Opioids Agonist Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Opioids Agonist Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Opioids Agonist Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 40. Americas Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Opioids Agonist Drugs Sales Market Share by Region in 2022
Figure 48. APAC Opioids Agonist Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 59. Europe Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Opioids Agonist Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs in 2022
Figure 77. Manufacturing Process Analysis of Opioids Agonist Drugs
Figure 78. Industry Chain Structure of Opioids Agonist Drugs
Figure 79. Channels of Distribution
Figure 80. Global Opioids Agonist Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Opioids Agonist Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Opioids Agonist Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Opioids Agonist Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Opioids Agonist Drugs Revenue Market Share Forecast by Application (2024-2029)
